Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
The Save Sight Institute (SSI) is a premier ophthalmic research and clinical center affiliated with the University of Sydney, Australia. It is dedicated to the prevention of blindness through a combination of laboratory research, clinical trials, and patient care. The institute is globally recognized for its 'Fight Retinal Blindness!' registry, which tracks real-world outcomes for macular diseases, and its pioneering work in gene therapy for inherited retinal disorders. SSI also provides specialist ophthalmic services and serves as a major center for postgraduate ophthalmic education. Its research spans from basic science to clinical application, aiming to translate discoveries into improved patient outcomes. The institute is located at the Sydney Eye Hospital, facilitating a direct link between scientific discovery and patient treatment.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Save Sight Institute.